CHICAGO - If two former U.S. presidents shared the stage to talk about the impact of the biotech industry and members of the press were not allowed to attend and report on it, did it really happen? (BioWorld Today - 2010 BIO) Read More
CHICAGO - The discovery of induced pluripotent stem (iPS) cells was made a scant three years ago, but already there is evidence of their unprecedented value in drug discovery and development. (BioWorld Today - 2010 BIO) Read More
WASHINGTON - InterMune Inc. failed to win FDA approval of Esbriet (pirfenidone) as a treatment for a fatal lung disease, known as idiopathic pulmonary fibrosis (IPF), despite the strong backing of an agency panel of experts. Read More
CHICAGO - Day two of 2010 Biotechnology Industry Organization convention kicked into high gear, and amid the early morning offerings was a panel session on gene patenting that its host dubbed "incredibly timely." (BioWorld Today - 2010 BIO) Read More
